You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Colorectal, colon, CRC, solid tumors, check point inhibitors, immunotherapy, metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

Recruiting
  • Metastatic Solid Tumor
  • +3 more
  • 1.0% IP-001 for Injection
  • Bordeaux, France
  • +9 more
Jan 26, 2023

Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

Not yet recruiting
  • Gastric
  • Colorectal Adenocarcinoma
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Nov 1, 2023

Advanced Solid Tumors Trial in Worldwide (Intervention)

Completed
  • Advanced Solid Tumors
  • Intervention
  • Birmingham, Alabama
  • +48 more
Jan 18, 2022

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

Completed
  • Colorectal Cancer
  • Fruquintinib combined with anti-PD-1 antibodies
  • ChangSha, Hunan, China
    Hunan Cancer Hospital
Aug 27, 2023

Advanced or Metastatic Solid Tumors Trial in United States (MDK-703, Checkpoint Inhibitor, Immune)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Sarasota, Florida
  • +4 more
Feb 10, 2023

Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

Recruiting
  • Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 18, 2023

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +5 more
    • Trastuzumab
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 31, 2023

    Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

    Active, not recruiting
    • Colon Adenocarcinoma
    • +10 more
    • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 12, 2022

    Advanced Therapies for Liver Metastases

    Recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • +2 more
      • Milan, Italy
        IRCCS San Raffaele
      Aug 8, 2022

      Colorectal Cancer Trial in Worldwide (Regorafenib, Atezolizumab, Imprime PGG)

      Recruiting
      • Colorectal Cancer
      • Duarte, California
      • +17 more
      Aug 3, 2022

      NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • +3 more
      • San Antonio, Texas
      • +1 more
      Sep 8, 2023

      NSCLC (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Trial in Irving, San Antonio,

      Not yet recruiting
      • Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors
      • Assigned interventions
      • Irving, Texas
      • +2 more
      Nov 7, 2023

      Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

      Terminated
      • Metastatic Colon Adenocarcinoma
      • +27 more
      • San Francisco, California
      • +1 more
      Jan 5, 2023

      Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +14 more
      • ELI-002 7P
      • (no location specified)
      Feb 3, 2023

      MSI, dMMR Colorectal Cancer Trial in Paris (Monalizumab/MEDI5257)

      Not yet recruiting
      • MSI
      • dMMR Colorectal Cancer
      • Paris, France
        Department of medical oncology - Saint-Antoine Hospital
      Nov 28, 2023

      Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)

      Active, not recruiting
      • Locally Advanced/Metastatic Solid Tumors
      • Newport Beach, California
      • +2 more
      Nov 10, 2023

      Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

      Recruiting
      • Advanced Solid Tumor
      • +24 more
      • MDNA11 Monotherapy
      • MDNA11 in combination with checkpoint inhibitor
      • Santa Monica, California
      • +7 more
      Nov 1, 2022

      Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

      Recruiting
      • Minimal Residual Disease
      • +11 more
      • ELI-002 2P
      • Duarte, California
      • +10 more
      Jan 18, 2023

      NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • +3 more
      • Boston, Massachusetts
      • +9 more
      Dec 22, 2022

      Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

      Not yet recruiting
      • Cancer
      • +8 more
      • DK210 (EGFR)
      • +3 more
      • (no location specified)
      Jan 27, 2023

      Advanced Solid Tumors, EGFR Positive NSCLC, Colorectal Carcinoma Trial in United States (TP-0903)

      Active, not recruiting
      • Advanced Solid Tumors
      • +4 more
      • Phoenix, Arizona
      • +15 more
      Apr 4, 2022